Epizyme Inc
F:EPE

Watchlist Manager

Epizyme Inc

F:EPE

Watchlist

Dividends

Price: 559 EUR 3.33% Market Closed

Market Cap: 92.2B EUR

Have any thoughts about
Epizyme Inc?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

Add Price Alert

Price Target:

Last Price: 559 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching false

Delete

Cancel

EPE Alert

Epizyme Inc

559

+18 (+3.33%)

52 Week Range	N/A N/A
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Epizyme Inc

What unique competitive advantages
does Epizyme Inc hold over its rivals?

What risks and challenges
does Epizyme Inc face in the near future?

Provide an overview of the primary business activities
of Epizyme Inc.

Show me price targets
for Epizyme Inc made by professional analysts.

Provide an overview of the primary business activities
of Epizyme Inc.

What unique competitive advantages
does Epizyme Inc hold over its rivals?

What risks and challenges
does Epizyme Inc face in the near future?

Show all valuation multiples
for Epizyme Inc.

Provide P/S
for Epizyme Inc.

Provide P/E
for Epizyme Inc.

Provide P/OCF
for Epizyme Inc.

Provide P/FCFE
for Epizyme Inc.

Provide P/B
for Epizyme Inc.

Provide EV/S
for Epizyme Inc.

Provide EV/GP
for Epizyme Inc.

Provide EV/EBITDA
for Epizyme Inc.

Provide EV/EBIT
for Epizyme Inc.

Provide EV/OCF
for Epizyme Inc.

Provide EV/FCFF
for Epizyme Inc.

Provide EV/IC
for Epizyme Inc.

Show me price targets
for Epizyme Inc made by professional analysts.

What are the Revenue projections
for Epizyme Inc?

How accurate were the past Revenue estimates
for Epizyme Inc?

What are the Net Income projections
for Epizyme Inc?

How accurate were the past Net Income estimates
for Epizyme Inc?

What are the EPS projections
for Epizyme Inc?

How accurate were the past EPS estimates
for Epizyme Inc?

What are the EBIT projections
for Epizyme Inc?

How accurate were the past EBIT estimates
for Epizyme Inc?

Compare the revenue forecasts
for Epizyme Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Epizyme Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Epizyme Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Epizyme Inc compared to its peers.

Compare the P/E ratios
of Epizyme Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Epizyme Inc with its peers.

Analyze the financial leverage
of Epizyme Inc compared to its main competitors.

Show all profitability ratios
for Epizyme Inc.

Provide ROE
for Epizyme Inc.

Provide ROA
for Epizyme Inc.

Provide ROIC
for Epizyme Inc.

Provide ROCE
for Epizyme Inc.

Provide Gross Margin
for Epizyme Inc.

Provide Operating Margin
for Epizyme Inc.

Provide Net Margin
for Epizyme Inc.

Provide FCF Margin
for Epizyme Inc.

Show all solvency ratios
for Epizyme Inc.

Provide D/E Ratio
for Epizyme Inc.

Provide D/A Ratio
for Epizyme Inc.

Provide Interest Coverage Ratio
for Epizyme Inc.

Provide Altman Z-Score Ratio
for Epizyme Inc.

Provide Quick Ratio
for Epizyme Inc.

Provide Current Ratio
for Epizyme Inc.

Provide Cash Ratio
for Epizyme Inc.

What is the historical Revenue growth
over the last 5 years for Epizyme Inc?

What is the historical Net Income growth
over the last 5 years for Epizyme Inc?

What is the current Free Cash Flow
of Epizyme Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Epizyme Inc.

Wall Street Price Targets Revenue Forecast Operating Income Forecast Net Income Forecast See Also

Section:

Wall Street Price Targets

Revenue Forecast

Operating Income Forecast

Net Income Forecast

Wall Street
Price Targets

EPE Price Targets Summary
Epizyme Inc

There are no price targets for EPE.

Lowest

Price Target

Not Available

Average

Price Target

Not Available

Highest

Price Target

Not Available

Epizyme Inc Competitors:
Price Targets

2315

Biocytogen Pharmaceuticals Beijing Co Ltd

20% Upside

UTHR

United Therapeutics Corp

39% Upside

DBV

DBV Technologies SA

203% Upside

4BB

4Basebio PLC

54% Upside

2315

Biocytogen Pharmaceuticals Beijing Co Ltd

20% Upside

UTHR

United Therapeutics Corp

39% Upside

DBV

DBV Technologies SA

203% Upside

4BB

4Basebio PLC

54% Upside

688235

Beigene Ltd

1% Upside

DTIL

Precision BioSciences Inc

345% Upside

ORY

Oryzon Genomics SA

192% Upside

ACAD

ACADIA Pharmaceuticals Inc

63% Upside

Revenue
Forecast

Revenue Estimate
Epizyme Inc

For the last 8 years the compound annual growth rate for Epizyme Inc's revenue is -7%. The projected CAGR for the next 1 year is 102%.

-7%

Past Growth

102%

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Epizyme Inc

Operating Income forecast
is not available for
Epizyme Inc

Net Income
Forecast

Net Income Estimate
Epizyme Inc

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

What is EPE's stock price target?

Not Available

EPE doesn't have any price targets made by Wall Street professionals.

What is Epizyme Inc's Revenue forecast?

Projected CAGR
102%

For the last 8 years the compound annual growth rate for Epizyme Inc's revenue is -7%. The projected CAGR for the next 1 year is 102%.

	Franklin Covey Co NYSE:FC	20.6397 USD -1.06%
	Mohawk Industries Inc NYSE:MHK	101.22 USD -0.2%
	Ardmore Shipping Corp NYSE:ASC	9.86 USD -1%
	ASGN Inc NYSE:ASGN	52.51 USD 0.79%
	Skyworks Solutions Inc NASDAQ:SWKS	66.34 USD 0.32%
	Weatherford International PLC NASDAQ:WFRD	44.055 USD 1.18%

	Johnson & Johnson NYSE:JNJ	154.07 USD -0.6%
	Bank of America Corp NYSE:BAC	41.0101 USD -0.27%
	Mastercard Inc NYSE:MA	561.025 USD -0.02%
	Salesforce Inc NYSE:CRM	273.18 USD 0.2%
	Abbvie Inc NYSE:ABBV	186.71 USD -4.77%
	Home Depot Inc NYSE:HD	359.58 USD -0.59%

	Arista Networks Inc NYSE:ANET	91.4925 USD 1.23%
	Visa Inc NYSE:V	348.245 USD -0.11%
	Texas Pacific Land Corp NYSE:TPL	1 327.1 USD 0.42%
	KLA Corp NASDAQ:KLAC	682.52 USD -1.55%
	Manhattan Associates Inc NASDAQ:MANH	183.175 USD -0.44%
	Monolithic Power Systems Inc NASDAQ:MPWR	628.87 USD 0.23%

	ServiceNow Inc NYSE:NOW	973.225 USD -0.49%
	EOG Resources Inc NYSE:EOG	109.2 USD 0.63%
	Monster Beverage Corp NASDAQ:MNST	60.121 USD -1.3%
	Copart Inc NASDAQ:CPRT	60.79 USD -0.43%
	Applied Materials Inc NASDAQ:AMAT	153.795 USD -0.53%
	Airbnb Inc NASDAQ:ABNB	122.085 USD -2.25%

Epizyme Inc
F:EPE